Chikungunya Vaccine Information for Healthcare Providers
Jan 30, 2025 · A live attenuated chikungunya vaccine (manufactured by Valneva as IXCHIQ) is the only chikungunya vaccine currently licensed in the United States. This vaccine was approved by the Food and Drug Administration (FDA) in November 2023.
For Healthcare Providers | IXCHIQ® (chikungunya vaccine, live) HCP
IXCHIQ is a vaccine indicated for the prevention of disease caused by chikungunya virus (CHIKV) in individuals 18 years of age and older who are at increased risk of exposure to CHIKV. This …
IXCHIQ | FDA
Jan 10, 2024 · For the prevention of disease caused by chikungunya virus (CHIKV) in individuals 18 years of age and older who are at high risk of exposure to CHIKV.
Chikungunya Vaccine | Chikungunya Virus | CDC - Centers for …
May 15, 2024 · One chikungunya vaccine (called IXCHIQ) is available in the United States. Some travelers at higher risk of exposure to chikungunya virus or at increased risk of severe disease should consider this vaccine.
FDA Approves First Vaccine to Prevent Disease Caused by …
The FDA approved Ixchiq, the first vaccine for prevention of disease caused by chikungunya virus in individuals 18 years of age and older who are at increased risk of exposure to...
Chikungunya Vaccine – IXCHIQ® - Valneva
The chikungunya vaccine IXCHIQ® is the world’s first and only licensed chikungunya vaccine available to address this significant unmet medical need. IXCHIQ® is approved in the United States, Canada and Europe.
Ixchiq: Uses, Dosage, Side Effects, Warnings - Drugs.com
Mar 26, 2024 · Ixchiq is a chikungunya virus vaccine used to prevent chikungunya disease, it is a live, weakened version of the chikungunya virus that helps build up an immune response to the chikungunya virus.
Nov 9, 2023 · IXCHIQ is a vaccine indicated for the prevention of disease caused by chikungunya virus (CHIKV) in individuals 18 years of age and older who are at increased risk of exposure to CHIKV. (1) This...
IXCHIQ for healthcare professionals – Valneva USA / Products
IXCHIQ is a vaccine indicated for the prevention of disease caused by chikungunya virus (CHIKV) in individuals 18 years of age and older who are at increased risk of exposure to CHIKV. This indication is approved under accelerated approval based …
IXCHIQ – Valneva USA / Products
IXCHIQ is a vaccine for use in individuals 18 years of age and older to help protect against chikungunya virus disease. You should still protect yourself from mosquito bites even if you have received the IXCHIQ vaccine.
- Some results have been removed